We are live on ! Find out more
ELTX icon

Elicio Therapeutics
ELTX

47 hedge funds and large institutions have $28.2M invested in Elicio Therapeutics in 2026 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

314% more call options, than puts

Call options by funds: $4.81M | Put options by funds: $1.16M

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

117% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 6

70% more capital invested

Capital invested by funds: $16.6M → $28.2M (+$11.7M)

27% more funds holding

Funds holding: 37 → 47 (+10)

2.46% more ownership

Funds ownership: 11.89% → 14.35% (+2.5%)

Holders
47
Holders Change
+10
Holders Change %
+27.03%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
13
Reduced
6
Closed
7
Calls
$4.81M
Puts
$1.16M
Net Calls
+$3.65M
Net Calls Change
+$5.95M

Top Buyers

Rank Fund Capital Flow
1
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$1.02M
2
Renaissance Technologies
Renaissance Technologies
New York
+$903K
3
Millennium Management
Millennium Management
New York
+$896K
4
Goldman Sachs
Goldman Sachs
New York
+$558K
5
IAM
Iridian Asset Management
Connecticut
+$290K

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$412K
2
Squarepoint
Squarepoint
New York
-$133K
3
OQS
Occudo Quantitative Strategies
Florida
-$126K
4
OAC
OMERS Administration Corp
Ontario, Canada
-$124K
5
JFG
Jefferies Financial Group
New York
-$95.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Knoll Capital Management
Florida
$6.74M – – –
VCM
2
Vanguard Capital Management
Pennsylvania
$5.54M +$5.01M +518,638 New
Balyasny Asset Management
3
Balyasny Asset Management
Illinois
$2.62M +$1.02M +106,052 +76%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$1.45M +$25.5K +2,646 +2%
Renaissance Technologies
5
Renaissance Technologies
New York
$1.3M +$903K +93,520 +333%
Millennium Management
6
Millennium Management
New York
$992K +$896K +92,762 New
Marshall Wace
7
Marshall Wace
United Kingdom
$797K -$412K -42,688 -36%
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$757K +$65.2K +6,752 +11%
VFT
9
Vanguard Fiduciary Trust
Pennsylvania
$740K +$668K +69,189 New
Northern Trust
10
Northern Trust
Illinois
$639K +$67.3K +6,965 +13%
Goldman Sachs
11
Goldman Sachs
New York
$618K +$558K +57,818 New
6CM
12
683 Capital Management
New York
$603K – – –
State Street
13
State Street
Massachusetts
$541K +$41.7K +4,320 +9%
BlackRock
14
BlackRock
New York
$541K +$52.3K +5,418 +12%
UBS Group
15
UBS Group
Switzerland
$361K +$16.9K +1,753 +5%
Morgan Stanley
16
Morgan Stanley
New York
$346K +$172K +17,851 +123%
IAM
17
Iridian Asset Management
Connecticut
$321K +$290K +30,051 New
CM
18
CM Management
Florida
$267K – – –
HF
19
HRT Financial
New York
$231K +$209K +21,611 New
Hudson Bay Capital Management
20
Hudson Bay Capital Management
Connecticut
$216K +$195K +20,208 New
BHCM
21
Brevan Howard Capital Management
Jersey
$186K +$168K +17,401 New
QC
22
Quadrature Capital
United Kingdom
$181K -$2.38K -247 -1%
Citadel Advisors
23
Citadel Advisors
Florida
$171K +$154K +15,978 New
Bank of America
24
Bank of America
North Carolina
$164K +$137K +14,176 +1,225%
MHC
25
Meyer Handelman Company
New York
$149K – – –
1
2 3

ELTX Hedge Fund Activity: Q1 2026 in Review

47 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Elicio Therapeutics (ELTX) for Q1 2026, worth a combined $28.2M — up 70% from $16.6M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ELTX positions and 7 closed out — a net gain of 12 holders — while 13 added to existing stakes and 6 trimmed.

The largest buyer was Balyasny Asset Management, adding an estimated $1.02M. The largest seller was Marshall Wace, cutting an estimated $412K.

  • 47 institutional investors held Elicio Therapeutics (ELTX) as of Q1 2026, up from 37 in Q4 2025.
  • Funds reported $28.2M of Elicio Therapeutics stock for Q1 2026, up 70% quarter-over-quarter.
  • 19 funds opened new Elicio Therapeutics positions in Q1 2026 and 7 closed out, a net change of +12 holders.
  • The largest Elicio Therapeutics buyer in Q1 2026 was Balyasny Asset Management, an estimated $1.02M added.
  • The largest Elicio Therapeutics seller in Q1 2026 was Marshall Wace, an estimated $412K sold.

Based on aggregated 13F filings for Q1 2026.